Terns Pharmaceuticals, Inc. (TERN)
USD 5.76
(-15.29%)
USD 5.76
(-15.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1 Million | - | - | - |
| Cost of Revenue | 881 Thousand | 1.03 Million | 512 Thousand | 394 Thousand | 195 Thousand | 65 Thousand |
| Gross Profit | -881 Thousand | -1.03 Million | 488 Thousand | -394 Thousand | -195 Thousand | -65 Thousand |
| Operating Expenses | 102.55 Million | 62.02 Million | 50.86 Million | 37.02 Million | 70.19 Million | 18.45 Million |
| Selling, General and Administrative Expenses | 39.06 Million | 22.41 Million | 19.54 Million | 8.99 Million | 8.66 Million | 3.9 Million |
| Research and Development Expenses | 63.49 Million | 39.61 Million | 31.31 Million | 28.02 Million | 61.53 Million | 14.55 Million |
| Other Expenses | - | -68 Thousand | 40 Thousand | -2.78 Million | 154 Thousand | 38 Thousand |
| Cost and Expenses | 102.55 Million | 62.02 Million | 50.86 Million | 37.02 Million | 70.19 Million | 18.45 Million |
| Operating Income | -102.55 Million | -62.02 Million | -49.86 Million | -37.02 Million | -70.19 Million | -18.45 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 239 Thousand | 358 Thousand | 508 Thousand | 813 Thousand | -20 Thousand | -67 Thousand |
| Earnings before Tax | -89.97 Million | -59.98 Million | -49.65 Million | -39.75 Million | -68.83 Million | -18.08 Million |
| Net Income | -90.21 Million | -60.34 Million | -50.15 Million | -40.57 Million | -68.81 Million | -17.71 Million |
| Earnings Per Share Basic | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| Earnings Per Share Diluted | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| Weighted Average Shares Outstanding | 71.25 Million | 36.03 Million | 25.26 Million | 25.12 Million | 25.09 Million | 23.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 71.25 Million | 36.03 Million | 25.26 Million | 25.12 Million | 25.09 Million | 23.97 Million |
| Gross Margin | - | - | 0.49 | - | - | - |
| EBIT Margin | - | - | -49.86 | - | - | - |
| Profit Margin | - | - | -50.16 | - | - | - |
| EBITDA | -102.26 Million | -58.95 Million | -49.34 Million | -36.63 Million | -35 Million | -18.39 Million |
| Earnings Before Tax Margin | - | - | -49.86 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.32 Million | - | - | - |
| Cost of Revenue | 240 Thousand | 236 Thousand | 220 Thousand | 881 Thousand | 222 Thousand | 217 Thousand |
| Gross Profit | -240 Thousand | -236 Thousand | 1.1 Million | -881 Thousand | -222 Thousand | -217 Thousand |
| Operating Expenses | 25.29 Million | 25.21 Million | 23.83 Million | 101.67 Million | 33.18 Million | 21.15 Million |
| Selling, General and Administrative Expenses | 6.94 Million | 6.62 Million | 6.37 Million | - | 18.35 Million | 7 Million |
| Research and Development Expenses | 18.35 Million | 18.58 Million | 17.45 Million | - | 14.83 Million | 14.15 Million |
| Other Expenses | -14 Thousand | -12 Thousand | -245 Thousand | - | -5000.00 | -60 Thousand |
| Cost and Expenses | 25.53 Million | 25.44 Million | 24.05 Million | 102.55 Million | 33.18 Million | 21.15 Million |
| Operating Income | -25.53 Million | -25.44 Million | -24.05 Million | -102.55 Million | -33.18 Million | -21.15 Million |
| Interest Expense | - | - | 2.56 Million | - | - | - |
| Income Tax Expense | 61 Thousand | 97 Thousand | 49 Thousand | 239 Thousand | 58 Thousand | 72 Thousand |
| Earnings before Tax | -22.67 Million | -22.27 Million | -20.97 Million | -89.97 Million | -29.7 Million | -17.82 Million |
| Net Income | -22.73 Million | -22.37 Million | -21.01 Million | -90.21 Million | -29.76 Million | -17.89 Million |
| Earnings Per Share Basic | -0.31 | -0.30 | -0.29 | - | -0.42 | -0.25 |
| Earnings Per Share Diluted | -0.31 | -0.30 | -0.29 | - | -0.42 | -0.25 |
| Weighted Average Shares Outstanding | 74.45 Million | 74.39 Million | 72.33 Million | 71.25 Million | 71.53 Million | 71.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.45 Million | 74.39 Million | 72.33 Million | 71.25 Million | 71.53 Million | 71.36 Million |
| Gross Margin | - | - | 0.83 | - | - | - |
| EBIT Margin | - | - | -18.03 | - | - | - |
| Profit Margin | - | - | -15.90 | - | - | - |
| EBITDA | -25.29 Million | -25.21 Million | -23.83 Million | - | -32.96 Million | -20.94 Million |
| Earnings Before Tax Margin | - | - | -18.20 | - | - | - |
GNRS
IKTIN
JAIPAN
FTREIT
AUTOAXLES
600807